PLACENTAL PATHOLOGY IN SYSTEMIC LUPUS-ERYTHEMATOSUS AND PHOSPHOLIPID ANTIBODY SYNDROME

Citation
Cm. Salafia et Al. Parke, PLACENTAL PATHOLOGY IN SYSTEMIC LUPUS-ERYTHEMATOSUS AND PHOSPHOLIPID ANTIBODY SYNDROME, Rheumatic diseases clinics of North America, 23(1), 1997, pp. 85
Citations number
72
Categorie Soggetti
Rheumatology
ISSN journal
0889857X
Volume
23
Issue
1
Year of publication
1997
Database
ISI
SICI code
0889-857X(1997)23:1<85:PPISLA>2.0.ZU;2-W
Abstract
Fetal loss is increased in women who meet the Arthritis and Rheumatism Association criteria for systemic lupus erythematosus (SLE) and in wo men who have phospholipid antibody syndrome (APS). There are multiple causes for this fetal loss, and in patients with SLE, disease activity appears to be an important contributing factor. Ln APS patients, it a ppears that some individuals will experience recurrent fetal loss and will continuously fail to complete pregnancy naturally. Placental exam ination has helped to elucidate some of the pathology that may contrib ute to this fetal loss and our studies have shown that the same pathol ogy is repeated in subsequent pregnancies. Placental examination in SL E or APS patients with recurrent fetal loss is vital if we are going t o be able to determine appropriate therapy to prevent fetal loss.